MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- BIOCON
BIOCON Share Price (BICN)
Here is the latest stock price and chart of Biocon. For more details, see the Biocon company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Watch Now: Replay of Our Explosive Profits Summit
| Live BSE Quotes | Dec 2, 2020 09:06:00 AM | ||
|---|---|---|---|
| Price (Rs)434.50 | Open (Rs) 434.50 | High (Rs) 434.50 | Low (Rs) 434.50 |
| % Change0.29 | Volume 0 | Value (Rs) 0 | 52-Week H/L 477.90 / 235.80 |
| Live NSE Quotes | Dec 2, 2020 9:07:39 AM | ||
|---|---|---|---|
| Price (Rs)435.00 | Open (Rs) 435.00 | High (Rs) 435.00 | Low (Rs) 435.00 |
| % Change0.39 | Volume 1,931 | Value (Rs) 839,985 | 52-Week H/L 478.00 / 235.55 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day 0.29% | 1 Month 7.55% | 3 Months 5.70% | 1 Year 51.95% | 5 Years (CAGR)* 40.74% | 10 Years (CAGR)* 20.44% |
* Compound Annual Growth Rate
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 12.88 | P/E Ratio (x) 33.73 | Market Cap (Rs m) 260,700.00 | P/BV (x) 4.28 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
BIOCON Share Price Today:
BIOCON share price is up 0.3% to Rs 434.5 on the BSE. On the NSE, the BIOCON share price is up 0.4% to Rs 435.0. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.3%. And the benchmark S&P BSE SENSEX is at 44,758.9 (up 0.2%).
Over the last 30 days, the BIOCON share price is up 5.0%. And over the last one year, BIOCON share price is up 57.1%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
Today's Market
SGX Nifty Up 21 Points, 5 Factors Helping the Sensex Rally, Burger King IPO, and Top Buzzing Stocks Today(Pre-Open)
Indian share markets continued momentum and ended their session on a strong note yesterday.
Related Views On News
BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)
Oct 29, 2020 | Updated on Oct 29, 2020For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)
Jan 24, 2020 | Updated on Jan 24, 2020For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsMost Popular
Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)
Nov 25, 2020India's drones directorate signals the next big defence tech multibaggers.
It's Time to Book Profits (Fast Profits Daily)
Nov 27, 2020In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.
How the New Margins Will Impact You (Fast Profits Daily)
Nov 25, 2020The new rules on margins will come into effect from 1st December. Are you ready?
Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)
Nov 27, 2020The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.
The Price of Dying, the Cost of Living (The Honest Truth)
Nov 20, 2020Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2021
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK BIOCON
- Track your investment in BIOCON with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON BIOCON
BIOCON - ACTAVIS COMPARISON
COMPARE BIOCON WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.